Evidence map›Paper›PMID 33531346›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

PON2 subverts metabolic gatekeeper functions in B cells to promote leukemogenesis.

Lili Pan, Chao Hong, Lai N Chan, Gang Xiao, Parmanand Malvi, Mark E Robinson, Huimin Geng, Srinivasa T Reddy, Jaewoong Lee, Vishal Khairnar and 7 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. A guide to B cell metabolism.Nature reviews. Immunology · 2026
    Review
  2. Paraoxonase 3 regulates the pore-forming α subunit of the large-conductance KBiochimica et biophysica acta. Molecular cell research · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Paraoxonase 2 is an ER chaperone that regulates the epithelial NaAmerican journal of physiology. Cell physiology · 2022
    Article
  11. Oncoimmunology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 2 countries.

Lili PanCenter of Molecular and Cellular Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT 06511; lainga.chan@yale.edu markus.muschen@yale.edu.ORCID 0000-0001-6326-3260
Chao HongDepartment of Laboratory Medicine, University of California, San Francisco, CA 94143; lainga.chan@yale.edu markus.muschen@yale.edu.ORCID 0000-0002-3678-4068
Lai N ChanCenter of Molecular and Cellular Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT 06511; lainga.chan@yale.edu markus.muschen@yale.edu.
Gang XiaoDepartment of Systems Biology, City of Hope Comprehensive Cancer Center, Monrovia, CA 91016.
Parmanand MalviDepartment of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 32533.ORCID 0000-0003-4101-5025
Mark E RobinsonCenter of Molecular and Cellular Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT 06511.
Huimin GengDepartment of Laboratory Medicine, University of California, San Francisco, CA 94143.
Srinivasa T ReddyDepartment of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095.
Jaewoong LeeCenter of Molecular and Cellular Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT 06511.
Vishal KhairnarDepartment of Systems Biology, City of Hope Comprehensive Cancer Center, Monrovia, CA 91016.
Kadriye Nehir CosgunCenter of Molecular and Cellular Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT 06511.
Liang XuDepartment of Systems Biology, City of Hope Comprehensive Cancer Center, Monrovia, CA 91016.
Kohei KumeCenter of Molecular and Cellular Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT 06511.ORCID 0000-0003-2856-5970
Teresa SadrasDepartment of Systems Biology, City of Hope Comprehensive Cancer Center, Monrovia, CA 91016.
Shaoyuan WangDepartment of Hematology, Fujian Provincial Key Laboratory of Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, 350001 Fujian, China.
Narendra WajapeyeeDepartment of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 32533.ORCID 0000-0003-3306-349X
Markus MüschenCenter of Molecular and Cellular Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT 06511; lainga.chan@yale.edu markus.muschen@yale.edu.
Yale Cancer Center · USCity of Hope · USFujian Medical University · CNUniversity of Alabama at Birmingham · USUniversity of California, San Francisco · USUniversity of California, Los Angeles · US

Funding

Metabolic gatekeepers in B-cell malignanciesR35CA197628 · NCI · YALE UNIVERSITY · PI Markus Müschen · 2016 to 2026
$11.7M
Targeting oncogenic TCR signaling in PTCLP01CA233412 · NCI · DANA-FARBER CANCER INST · PI KNOECHEL, BIRGIT · 2019 to 2023
$8.7M
Targeted activation of autoimmune checkpoints in B cell malignanciesR01CA157644 · NCI · YALE UNIVERSITY · PI Markus Müschen · 2011 to 2026
$5.7M
CD25-mediated feedback control of BCR-signaling and its oncogenic mimicsR01CA213138 · NCI · YALE UNIVERSITY · PI MÜSCHEN, MARKUS · 2017 to 2022
$1.9M
Howard Hughes Medical Institute 55108547NCI NIH HHS P01 CA233412NCI NIH HHS R01 CA157644NCI NIH HHS R01 CA213138NCI NIH HHS R35 CA197628
6 · The paper itself

Abstract

Unlike other cell types, developing B cells undergo multiple rounds of somatic recombination and hypermutation to evolve high-affinity antibodies. Reflecting the high frequency of DNA double-strand breaks, adaptive immune protection by B cells comes with an increased risk of malignant transformation. B lymphoid transcription factors (e.g., IKZF1 and PAX5) serve as metabolic gatekeepers by limiting glucose to levels insufficient to fuel transformation. We here identified aberrant expression of the lactonase PON2 in B cell acute lymphoblastic leukemia (B-ALL) as a mechanism to bypass metabolic gatekeeper functions. Compared to normal pre-B cells, PON2 expression was elevated in patient-derived B-ALL samples and correlated with poor clinical outcomes in pediatric and adult cohorts. Genetic deletion of

Indexed as

Adenosine TriphosphateAnimalsAryldialkylphosphataseB-LymphocytesCarcinogenesisCell Line, TumorCells, CulturedGlucoseGlucose Transporter Type 1HumansMembrane ProteinsMiceMice, Inbred C57BLPrecursor Cell Lymphoblastic Leukemia-LymphomaProtein BindingAdenosine TriphosphateAryldialkylphosphataseGlucoseGlucose Transporter Type 1Membrane ProteinsPON2 protein, humanSLC2A1 protein, humanSTOM protein, humanB cell leukemiaglucose transportlactonaseparaoxonase 2

Identifiers

PMID33531346
PMCPMC7896313
OpenAlexW3127375091

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.